Federal drug reviewers think Johnson & Johnson’s experimental diabetes drug might bring heart risks because it raised cholesterol levels in patient testing.
Read more
FDA staff: J&J diabetes drug may pose heart risk
Posted in Drugs
-
-
Recent Posts
-
-